Optimizing the implementation of tobacco use treatment in the context of lung cancer screening

Working with the Lung Cancer Alliance, 18 heterogeneous lung cancer screening sites were observed to To estimate the cost and incremental cost-effectiveness of evidence based tobacco treatment components and creating effective models for smoking cessation treatment in lung cancer screening settings.